GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 52 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $0 | – | 324 | +1017.2% | 0.00% | – |
Q1 2023 | $0 | – | 29 | -90.2% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 296 | -88.2% | 0.00% | – |
Q3 2021 | $10,000 | -44.4% | 2,500 | -53.7% | 0.00% | – |
Q2 2021 | $18,000 | +157.1% | 5,397 | +60.4% | 0.00% | – |
Q1 2021 | $7,000 | -12.5% | 3,364 | -6.0% | 0.00% | – |
Q4 2020 | $8,000 | +300.0% | 3,580 | +320.2% | 0.00% | – |
Q3 2020 | $2,000 | -50.0% | 852 | -28.2% | 0.00% | – |
Q2 2020 | $4,000 | -83.3% | 1,186 | -90.1% | 0.00% | – |
Q1 2020 | $24,000 | +700.0% | 12,012 | +865.6% | 0.00% | – |
Q4 2019 | $3,000 | -40.0% | 1,244 | -11.8% | 0.00% | – |
Q3 2019 | $5,000 | 0.0% | 1,410 | +28.2% | 0.00% | – |
Q2 2019 | $5,000 | -16.7% | 1,100 | 0.0% | 0.00% | – |
Q1 2019 | $6,000 | +50.0% | 1,100 | 0.0% | 0.00% | – |
Q4 2018 | $4,000 | -77.8% | 1,100 | -62.4% | 0.00% | – |
Q3 2018 | $18,000 | +80.0% | 2,925 | +82.8% | 0.00% | – |
Q2 2018 | $10,000 | +233.3% | 1,600 | +166.7% | 0.00% | – |
Q1 2018 | $3,000 | +50.0% | 600 | -13.3% | 0.00% | – |
Q4 2017 | $2,000 | – | 692 | +2561.5% | 0.00% | – |
Q3 2017 | $0 | – | 26 | +766.7% | 0.00% | – |
Q2 2017 | $0 | – | 3 | -98.2% | 0.00% | – |
Q4 2016 | $0 | – | 167 | +247.9% | 0.00% | – |
Q2 2016 | $0 | – | 48 | -81.2% | 0.00% | – |
Q4 2015 | $0 | – | 255 | -39.6% | 0.00% | – |
Q3 2015 | $0 | – | 422 | +58.1% | 0.00% | – |
Q2 2015 | $0 | – | 267 | +167.0% | 0.00% | – |
Q1 2015 | $0 | – | 100 | 0.0% | 0.00% | – |
Q4 2014 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
Q3 2014 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q2 2014 | $1,000 | -50.0% | 100 | 0.0% | 0.00% | – |
Q1 2014 | $2,000 | +100.0% | 100 | -10.7% | 0.00% | – |
Q4 2013 | $1,000 | 0.0% | 112 | +12.0% | 0.00% | – |
Q3 2013 | $1,000 | 0.0% | 100 | -60.0% | 0.00% | – |
Q2 2013 | $1,000 | – | 250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cutter & CO Brokerage, Inc. | 129,488 | $271,925 | 0.08% |
Geneos Wealth Management Inc. | 427,400 | $897,540 | 0.06% |
SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $25,200 | 0.02% |
Vivaldi Capital Management LP | 19,261 | $40,448 | 0.01% |
Beacon Capital Management, LLC | 12,605 | $26,471 | 0.01% |
Atria Wealth Solutions, Inc. | 263,300 | $552,930 | 0.01% |
Wealthspire Advisors, LLC | 183,862 | $386,111 | 0.01% |
BARRETT & COMPANY, INC. | 4,984 | $10,466 | 0.01% |
OSAIC HOLDINGS, INC. | 1,271,760 | $2,670,656 | 0.01% |
Ameritas Advisory Services, LLC | 45,302 | $94,856 | 0.01% |